Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005
- PMID: 17190630
- DOI: 10.1016/j.jaad.2006.06.006
Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005
Abstract
Topical photodynamic therapy (PDT) is used to treat nonmelanoma skin cancers, such as actinic keratoses, Bowen's disease, and basal cell carcinoma (superficial and nodular). This article presents up-to-date, practical, evidence-based recommendations on the use of topical PDT using 5-aminolevulinic acid or methyl aminolevulinate for the treatment (and prevention) of nonmelanoma skin cancers. A systematic literature review was conducted (using MEDLINE), and recommendations were made on the basis of the quality of evidence for efficacy, safety/tolerability, cosmetic outcome, and patient satisfaction/preference. Topical PDT is highly effective in the treatment of actinic keratoses, Bowen's disease, superficial and thin nodular basal cell carcinomas, with cosmesis typically superior to that achieved with existing standard therapies. PDT may also be a means of preventing certain nonmelanoma skin cancers in immunosuppressed patients.
Similar articles
-
Photodynamic therapy for nonmelanoma skin cancers. Current review and update.Mol Immunol. 2003 Jul;39(17-18):1133-6. doi: 10.1016/s0161-5890(03)00083-x. Mol Immunol. 2003. PMID: 12835091 Review.
-
Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers.Skin Therapy Lett. 2009 Jul-Aug;14(6):1-3. Skin Therapy Lett. 2009. PMID: 19609473 Review.
-
Methyl aminolevulinate: actinic keratoses and Bowen's disease.Dermatol Clin. 2007 Jan;25(1):81-7. doi: 10.1016/j.det.2006.09.009. Dermatol Clin. 2007. PMID: 17126745 Review.
-
Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma.J Eur Acad Dermatol Venereol. 2001 Nov;15(6):550-4. doi: 10.1046/j.1468-3083.2001.00333.x. J Eur Acad Dermatol Venereol. 2001. PMID: 11843215 Clinical Trial.
-
Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer.Br J Dermatol. 2007 May;156(5):793-801. doi: 10.1111/j.1365-2133.2007.07833.x. Epub 2007 Apr 5. Br J Dermatol. 2007. PMID: 17419691 Review.
Cited by
-
Nonsurgical innovations in the treatment of nonmelanoma skin cancer.J Clin Aesthet Dermatol. 2010 Jun;3(6):20-34. J Clin Aesthet Dermatol. 2010. PMID: 20725548 Free PMC article.
-
Actinic keratoses: a comprehensive update.J Clin Aesthet Dermatol. 2009 Jul;2(7):43-8. J Clin Aesthet Dermatol. 2009. PMID: 20729970 Free PMC article.
-
Significant improvement of facial actinic keratoses after blue light photodynamic therapy with oral vitamin D pretreatment: An interventional cohort-controlled trial.J Am Acad Dermatol. 2022 Jul;87(1):80-86. doi: 10.1016/j.jaad.2022.02.067. Epub 2022 Mar 18. J Am Acad Dermatol. 2022. PMID: 35314199 Free PMC article. Clinical Trial.
-
Fabrication of Red Blood Cell-Based Multimodal Theranostic Probes for Second Near-Infrared Window Fluorescence Imaging-Guided Tumor Surgery and Photodynamic Therapy.Theranostics. 2019 Jan 1;9(2):369-380. doi: 10.7150/thno.29817. eCollection 2019. Theranostics. 2019. PMID: 30809280 Free PMC article.
-
Photodynamic diagnosis with methyl-5-aminolevulinate in squamous intraepithelial lesions of the vulva: Experimental research.PLoS One. 2018 May 9;13(5):e0196753. doi: 10.1371/journal.pone.0196753. eCollection 2018. PLoS One. 2018. PMID: 29742173 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical